Please login to the form below

Not currently logged in
Email:
Password:

insulin

This page shows the latest insulin news and features for those working in and with pharma, biotech and healthcare.

Sanofi poaches Peugeot's finance head

Sanofi poaches Peugeot's finance head

The group saw sales from its diabetes blockbuster Lantus (insulin glargine) plummet 18% to 911m (1.1bn) in the first quarter, quite a difference from the drug’s peak in 2014,

Latest news

More from news
Approximately 72 fully matching, plus 464 partially matching documents found.

Latest Intelligence

  • Mylan sees the UK paving the way for an insulin game changer Mylan sees the UK paving the way for an insulin game changer

    As biosimilars surge into the insulin market, governments  are urged to seize ‘the opportunity of the century’. ... With insulin, we  are creating new educational and awareness programmes based on the fact that biosimilars come at a better value

  • Managing medication non-adherence Managing medication non-adherence

    One Drop, the digital diabetes mHealth app, has recently shown that AC1 levels are reduced by 1% in people using the app to track their insulin, glucose, activity and food.

  • When science is not enough When science is not enough

    Destructive. Given that Pfizer had to pull its powder-based insulin drug Exubera after it had returned just $13m in sales from an 11-year $2.8bn development project, it seems

  • Deal Watch May 2016 Deal Watch May 2016

    Similarly, Bristol-Myers Squibb has called time on its deal with Biocon for IN-105/Tregopil [oral insulin].

  • Harnessing commercial innovation Harnessing commercial innovation

    We needed to ensure that people were safe. Then we needed to ensure that our insulin was made available to people in Japan. ... From our own point of view, we need to ensure that our devices have connectivity - you need to be able to store and transfer

More from intelligence
Approximately 0 fully matching, plus 34 partially matching documents found.

Latest appointments

  • Emperra appoints Bent Johnsen as CEO Emperra appoints Bent Johnsen as CEO

    Johnsen’s expertise lies in the health care sector and he has held several executive leadership positions within the field of diabetes working for insulin manufacturing companies as well as other

  • Novo Nordisk appoints Liz Skrbkova Novo Nordisk appoints Liz Skrbkova

    She will move from the company's UK team to take up a role in Søborg, Denmark, where she will focus on the company's modern insulin and device portfolio.

  • Adocia names senior members of new US subsidiary Adocia names senior members of new US subsidiary

    He joins from Halozyme Pharmaceuticals, where he held the position of executive medical director and worked on the ultra-rapid insulin programme. ... He most recently served as VP of commercial at Halozyme, also on the ultra-rapid insulin programme.

  • JDRF names new CEO JDRF names new CEO

    pancreas to deliver insulin in people with type 1 diabetes.

  • Hanspeter Spek to retire from Sanofi Hanspeter Spek to retire from Sanofi

    During his time at Sanofi, he has helped with the success of several significant products, including bloodthinner Plavix, insulin Lantus and cancer drug Taxotere.

More from appointments
Approximately 0 fully matching, plus 7 partially matching documents found.

Latest from PMHub

  • Training the next generation of biotech leaders

    Manufacturing for these products is going to look very different to the process used for large-scale production of biotech products, like recombinant insulin.” Ivan explains. “

  • CES 2017 – Medical Device Top Picks

    CES 2017 – Medical Device Top Picks. Connected tech was the overriding theme at this year's Consumer Electronics Show in Las Vegas. But among all that consumer gadgetry, there were some great medical devices too. So what are the ones to watch in

  • Could hackers threaten your health?

    cybersecurity. After being hit by recent discoveries of security flaws in on-the-market insulin pumps, pacemakers, and infusion pumps, cyber security researchers and medical suppliers are even considering a “ Hippocratic

  • Blog: Digital therapeutics: within our reach?

    Clipsulin device: automatically counts and transmits the number of injected doses of insulin to your mobile phone, helping you to keep track of your treatment.

  • Pegasus

    Liz Skrbkova - Global Communications Manager, Modern Insulins &Devices, Novo Nordisk Global:. “

More from PMHub
Approximately 1 fully matching, plus 6 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Aptus Health

Aptus Health is dedicated to advancing health engagement. The company offers end-to-end digital health engagement solutions spanning all areas of...

Latest intelligence

Developing advocacy in the pharmaceutical industry.
The importance of advocacy programmes...
GDPR and events. What does the pharma industry need to know?
Many people in the pharma industry still aren’t following the rules set out by the GDPR when it comes to running events and attending tradeshows. But with eye-watering fines for...
Digital trends in B2B sales - how far behind is Pharma?
The modern approach to B2B sales is data-driven, and enabled by digital tools....

Infographics